Expand CNTA Menu
CNTA MENU

CNTA Latest Press Releases

-- April 10, 2026 --

Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? PRNewswire 1:34 PM

-- April 8, 2026 --

SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS PRNewswire 2:15 PM

-- April 7, 2026 --

Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders? PRNewswire 2:48 PM
Halper Sadeh LLC is Investigating Whether APLS, CNTA, KZR, EQH are Obtaining Fair Deals for their Shareholders Globe Newswire 9:50 AM
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders Globe Newswire 7:31 AM

-- April 2, 2026 --

Halper Sadeh LLC is Investigating Whether APLS, CNTA, EQH, VYNE are Obtaining Fair Deals for their Shareholders Globe Newswire 8:32 AM

-- April 1, 2026 --

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA) PRNewswire 4:15 PM

-- March 31, 2026 --

Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA Business Wire 10:19 PM
Halper Sadeh LLC is Investigating Whether APLS, CNTA, BIRD, WBD are Obtaining Fair Deals for their Shareholders Globe Newswire 7:01 PM
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders PRNewswire 12:07 PM
Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders? PRNewswire 11:38 AM
CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders Business Wire 8:11 AM
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders PRNewswire 6:45 AM

-- February 3, 2026 --

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- January 14, 2026 --

Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting Globe Newswire 5:00 PM

-- December 11, 2025 --

Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes